Dynatronics Corp. (DYNT) Enterprise Value to EBITDA Ratio
The disruption of global supply chains due to conflicts is delaying the arrival of components for Dynatronics Corporation (DYNT), while sanctions are hindering the sale of rehabilitation equipment in closed regions. Expansion is further complicated by US export restrictions and challenges regarding the certification of devices abroad. The business relies on a stable niche with moderate leverage and fixed efficiency. The current EV/EBITDA price action is .
Comprehensive metric breakdowns and analytics for dynatronics.com (DYNT)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
DYNT - Net Financial Result|Projected Future Earnings Dynatronics Corporation|DYNT - Price to Earnings Ratio|Forward P/E Multiple Dynatronics|DYNT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics Corporation|DYNT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Dynatronics|DYNT - Earnings per share for the trailing year|Quarterly EPS earnings growth dynatronics.com|DYNT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Dynatronics Corporation
Analysis of all company metrics:Dynatronics Corp. DYNT
Amidst the operational restructuring of Dynatronics Corporation (DYNT), this indicator becomes a key tool for monitoring the efficiency of asset optimization. The ratio correlates the total enterprise value, including net debt, with operating profit before depreciation and amortization, thereby determining the investment payback period. By analyzing changes in the EV/EBITDA ratio, an investor can assess the extent to which the company's market value aligns with its actual ability to generate cash flow.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|TNON: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation LFWD|Enterprise Value to EBITDA Ratio AMIX|Company Value to EBITDA INVO Bioscience IVF|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bone Biologics Corporation (BBLG)|Axonics, Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BIOL (BIOLASE, Inc.)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO: Enterprise Value to EBITDA Ratio
